Matthew M. Gosling
2011
In 2011, Matthew M. Gosling earned a total compensation of $924.3K as Senior Vice President and General Counsel at DepoMed, a 53% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $117,074 |
|---|---|
| Option Awards | $449,670 |
| Salary | $355,470 |
| Other | $2,098 |
| Total | $924,312 |
Gosling received $449.7K in option awards, accounting for 49% of the total pay in 2011.
Gosling also received $117.1K in non-equity incentive plan, $355.5K in salary and $2.1K in other compensation.
Rankings
In 2011, Matthew M. Gosling's compensation ranked 5,933rd out of 10,747 executives tracked by ExecPay. In other words, Gosling earned more than 44.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,933 out of 10,747 | 45th |
Division Manufacturing | 2,146 out of 3,960 | 46th |
Major group Chemicals And Allied Products | 479 out of 1,033 | 54th |
Industry group Drugs | 307 out of 781 | 61st |
Industry Pharmaceutical Preparations | 244 out of 571 | 57th |
Source: SEC filing on April 4, 2014.
Gosling's colleagues
We found three more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2011.